» Articles » PMID: 32397212

Alpha Radiation As a Way to Target Heterochromatic and Gamma Radiation-Exposed Breast Cancer Cells

Overview
Journal Cells
Publisher MDPI
Date 2020 May 14
PMID 32397212
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Compact chromatin is linked to a poor tumour prognosis and resistance to radiotherapy from photons. We investigated DNA damage induction and repair in the context of chromatin structure for densely ionising alpha radiation as well as its therapeutic potential. Chromatin opening by histone deacetylase inhibitor trichostatin A (TSA) pretreatment reduced clonogenic survival and increased γH2AX foci in MDA-MB-231 cells, indicative of increased damage induction by free radicals using gamma radiation. In contrast, TSA pretreatment tended to improve survival after alpha radiation while γH2AX foci were similar or lower; therefore, an increased DNA repair is suggested due to increased access of repair proteins. MDA-MB-231 cells exposed to fractionated gamma radiation (2 Gy × 6) expressed high levels of stem cell markers, elevated heterochromatin H3K9me3 marker, and a trend towards reduced clonogenic survival in response to alpha radiation. There was a higher level of H3K9me3 at baseline, and the ratio of DNA damage induced by alpha vs. gamma radiation was higher in the aggressive MDA-MB-231 cells compared to hormone receptor-positive MCF7 cells. We demonstrate that heterochromatin structure and stemness properties are induced by fractionated radiation exposure. Gamma radiation-exposed cells may be targeted using alpha radiation, and we provide a mechanistic basis for the involvement of chromatin in these effects.

Citing Articles

Fractionated alpha and mixed beam radiation promote stronger pro-inflammatory effects compared to acute exposure and trigger phagocytosis.

Karimi Roshan M, Belikov S, Ix M, Protti N, Balducci C, Dodel R Front Cell Neurosci. 2024; 18:1440559.

PMID: 39717389 PMC: 11663654. DOI: 10.3389/fncel.2024.1440559.


Optimization Processes of Clinical Chelation-Based Radiopharmaceuticals for Pathway-Directed Targeted Radionuclide Therapy in Oncology.

Tomiyoshi K, Wilson L, Mourtada F, Mourtada J, Namiki Y, Kamata W Pharmaceutics. 2024; 16(11).

PMID: 39598580 PMC: 11597032. DOI: 10.3390/pharmaceutics16111458.


Melanoma Cells from Different Patients Differ in Their Sensitivity to Alpha Radiation-Mediated Killing, Sensitivity Which Correlates with Cell Nuclei Area and Double Strand Breaks.

Levy O, Altaras A, Binyamini L, Sagi-Assif O, Izraely S, Cooks T Cancers (Basel). 2024; 16(22).

PMID: 39594759 PMC: 11592378. DOI: 10.3390/cancers16223804.


Chromosomal damage, gene expression and alternative transcription in human lymphocytes exposed to mixed ionizing radiation as encountered in space.

Riego M, Meher P, Brzozowska B, Akuwudike P, Bucher M, Oestreicher U Sci Rep. 2024; 14(1):11502.

PMID: 38769353 PMC: 11106305. DOI: 10.1038/s41598-024-62313-7.


Actinium-225 Targeted Agents: Where Are We Now?.

Mourtada F, Tomiyoshi K, Sims-Mourtada J, Mukai-Sasaki Y, Yagihashi T, Namiki Y Brachytherapy. 2023; 22(6):697-708.

PMID: 37690972 PMC: 10840862. DOI: 10.1016/j.brachy.2023.06.228.


References
1.
Falk M, Lukasova E, Kozubek S . Chromatin structure influences the sensitivity of DNA to gamma-radiation. Biochim Biophys Acta. 2008; 1783(12):2398-414. DOI: 10.1016/j.bbamcr.2008.07.010. View

2.
Phillips T, McBride W, Pajonk F . The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst. 2006; 98(24):1777-85. DOI: 10.1093/jnci/djj495. View

3.
Yu Y, Chiou G, Huang P, Lo W, Wang C, Lu K . Network biology of tumor stem-like cells identified a regulatory role of CBX5 in lung cancer. Sci Rep. 2012; 2:584. PMC: 3419921. DOI: 10.1038/srep00584. View

4.
Oertel S, Thiemann M, Richter K, Weber K, Huber P, Lopez Perez R . Combination of suberoylanilide hydroxamic acid with heavy ion therapy shows promising effects in infantile sarcoma cell lines. Radiat Oncol. 2011; 6:119. PMC: 3213106. DOI: 10.1186/1748-717X-6-119. View

5.
de Kruijff R, Wolterbeek H, Denkova A . A Critical Review of Alpha Radionuclide Therapy-How to Deal with Recoiling Daughters?. Pharmaceuticals (Basel). 2015; 8(2):321-36. PMC: 4491664. DOI: 10.3390/ph8020321. View